Skip to main content
. 2017 Nov 28;25(5):875–880. doi: 10.1016/j.sjbs.2017.11.051

Table 3.

Mean of the relative abundance of dominant phyla and families in stool samples obtained at baseline and after 6 months of follow-up in healthy and CMA infants.

Dominant taxa* Baseline
Six months
Infants with CMA
(n = 60)
Median (IQR)
Control
(n = 60)
Median (IQR)
p value FDRp Infants with CMA
(n = 60)
Median (IQR)
Control
(n = 60)
Median (IQR)
p value FDRp
Actinobacteria 6.0 (0.3–22.2) 4.7 (1.2–12.8) 0.69 0.85 0.5 (0.0–1.7) 8.3 (3.6–14.6) 0.04 0.05
 Bifidobacteriaceae 6.0 (0.0–22.1) 4.6 (1.0–12.3) 0.79 0.94 0.3 (0.0–1.6) 8.2 (3.6–14.5) 0.03 0.04
Bacteroidetes 2.1 (0.3–21.8) 31.3 (0.4–61.3) 0.02 0.05 38.1 (12.4–52.6) 47.8 (40.0–61.3) 0.09 0.25
 Bacteroidaceae 0.4 (0.1–7.5) 28.4 (0.1–57.8) 0.01 0.04 33.2 (10.5–47.0) 37.6 (29.5–55.8) 0.09 0.25
Firmicutes 21.7 (13.3–36.4) 23.9 (7.9–50.1) 0.56 0.95 33.4 (25.6–57.1) 34.2 (26.1–43.6) 0.58 0.67
 Lactobacillaceae 0.1 (0.0–2.1) 0.2 (0.3–3.8) 0.58 0.69 6.3 (0.6–11.2) 0.5 (0.1–4.8) 0.04 0.04
 Veillonellaceae 3.0 (0.7–13.9) 5.1 (0.9–17.7) 0.51 0.80 6.7 (0.7–15.3) 3.9 (1.5–9.2) 0.51 0.55
 Lachnospiraceae 1.2 (0.1–3.0) 1.4 (0.1–7.5) 0.44 0.69 6.9 (0.5–19.0) 9.3 (3.9–20.5) 0.33 0.57
 Ruminococcaceae 0.1 (0.0–2.6) 0.1 (0.0–2.2) 0.87 0.87 1.5 (1.2–7.6) 10.5 (2.4–13.9) 0.03 0.03
Proteobacteria 46.0 (27.0–78.9) 18.1 (8.7–37.0) 0.006 0.01 7.9 (3.0–20.1) 5.7 (2.5–8.6) 0.21 0.33
 Alcaligenaceae 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.86 0.96 0.1 (0.0–2.3) 1.6 (0.0–2.9) 0.27 0.37
 Enterobacteriaceae 46.0 (27.0–78.1) 17.1 (6.6–35.9) 0.004 0.01 6.9 (2.3–7.6) 3.7 (0.3–5.2) 0.09 0.22
E/B Ratio 115.8 (10.3–299.0) 0.8 (0.2–154.4) 0.0002 0.003 0.22 (0.07–16.69) 0.10 (0.01–0.19) 0.06 0.11

CMA, Cow’s milk allergy; IQR, Interquartile range; E/B, Enterobacteriacea/Bacteroidaceae; FDR, false discovery rate.

*

Dominant taxa have overall median relative abundance >1% at baseline and/or 6 months; phyla are in plain text and families are italicized. Comparisons by nonparametric Kruskal–Wallis test with FDR correction for multiple testing.